ロード中...
The Efficacy of Vildagliptin Concomitant With Insulin Therapy in Type 2 Diabetic Subjects
BACKGROUND: In Japan, dipeptidyl peptidase 4 (DPP4) inhibitors have become standard therapeutic agents for type 2 diabetes, and numbers of patients receiving insulin therapy combined with DPP4 inhibitors, which is a highly effective regimen, are increasing. METHODS: In this study, we evaluated the e...
保存先:
| 出版年: | J Clin Med Res |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elmer Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356089/ https://ncbi.nlm.nih.gov/pubmed/25780477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2057w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|